Corrigendum to "A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone": [ESMO Open 8 (2023) 102033]
ESMO Open. 2024 Jun;9(6):103621.
doi: 10.1016/j.esmoop.2024.103621.
Epub 2024 Jun 13.
1 The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool.
2 The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool.
3 The Walton NHS Foundation Trust, Liverpool, UK.
4 Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool.
5 The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool. Electronic address: c.palmieri@liverpool.ac.uk.